Method of Treating Skin with microRNA Modulators
AssigneeAvon Products, Inc.
InventorsPermanan Raaj Khusial, Uma Santhanam, John W. Lyga
Life of this patent
Estimating the term…
Abstract
Methods for preventing, ameliorating, or reducing dermatological signs of aging are provided which employ active agents that suppress or down-regulate microRNA expression in dermal fibroblast, resulting in enhanced production of collagen, elastin and/or fibrillin in the skin. Also provided are methods for screening for activity against specific microRNAs and the methods of using active agents identified by the screening protocol in the treatment of skin.
Claims15
A method for improving the aesthetic appearance of human skin comprising topically applying to an area of the skin in need thereof an effective amount of an active agent that suppresses miR-29a, having the sequence UAGCACCAUCUGAAAUCGGUUA (SEQ. ID. No.:
- 1), and/or miR-29b, having the sequence UAGCACCAUUUGAAAUCAGUGUU (SEQ. ID No.:
- 2), in a cosmetically acceptable vehicle, for a time sufficient to enhance the production of collagen, elastin, and/or fibrillin in the skin,
- wherein said active agent is a compound having the structure of formula II:
- wherein,
- R5, when not hydrogen, is selected from hydrogen;
- —R or X1;
- where “m” is an integer from 1 to 4, and, in the case where “m” is 2, 3 or 4, R5 is independently selected at each occurrence;
- and
- R7 and R8 are independently C1-20 hydrocarbon radicals;
- wherein said C1-20 hydrocarbon radicals may optionally be substituted with a group X1 and/or with from one to six heteroatoms selected from oxygen, nitrogen, and sulfur;
- R, R*, and RN are independently hydrogen or a C1-20 hydrocarbon radical;
- wherein said C1-20 hydrocarbon radical may optionally be substituted with a group X1 and/or with from one to twelve heteroatoms selected from oxygen, nitrogen, and sulfur;
- and
- X1 is selected from the group consisting of —F;
- —Cl;
- —Br;
- —I;
- —OH;
- —C≡C—R*;
- —C≡N;
- —C(R)═N—RN;
- —C═N—N(RN)2;
- —C(═NRN)—N(RN)2;
- —CH2OH;
- —CHO;
- —(C═O)—R*;
- —CO2H;
- —CO2−;
- —CO2R*;
- —CS2R*;
- —(C═O)—S—R*;
- —S—(C═O)—R*;
- —(C═O)—NH2;
- —(C═O)—NRNRN;
- —(C═O)—NHNH2;
- —O—(C═O)—NHNH2;
- —(C═S)—NH2;
- —(C═S)—N(RN)2;
- —O—(C═O)—H;
- —O—(C═O)—R*;
- —O—(C═O)—NH2;
- —O—(C═O)—NRNRN;
- —OR*;
- —SR*;
- —NH2;
- —NHRN;
- —NRN2;
- —N(RN)3+;
- —N(RN)—OH;
- —N(→O)(R*)2;
- —O—N(RN)2;
- —N(RN)—O—R*;
- —N(RN)—N(RN)2;
- —NRN—(C═O)—R*;
- —NRNC(═O)O—R*;
- —NRN—CHO;
- —NRN—(C═O)—R*;
- —NRNC(═O)NRN;
- —N(RN)—C(═O)—N(RN)2;
- —N(RN)—C(═S)—N(RN)2;
- —N═C(R*)2;
- —N═N—RN;
- —SCN;
- —NCS;
- —NSO;
- —SS—R*;
- —SO—R*;
- —SO2—R*;
- —O—S(═O)2—R*;
- —S(═O)2—OR*;
- —N(RN)—SO2—R*;
- —SO2—N(R*)2;
- —O—SO3−;
- —O—S(═O)2—OR*;
- —O—S(═O)—OR*;
- —O—S(═O)—R*;
- —S(═O)—OR*;
- —S(═O)—R*;
- —NO;
- —NO2;
- —NO3;
- —O—NO;
- —O—NO2;
- —N3;
- —N2;
- —N(C2H4);
- —Si(R*)3;
- —CF3;
- —O—CF3;
- —(C═O)—R*;
- —P(R*)2;
- —O—P(═O)(OR*)2;
- and —P(═O)(OR*)2;
- and cosmetically acceptable salts thereof.
A method for identifying active agents useful for improving the aesthetic appearance of skin comprising assaying candidate substances for ability to suppress or down-regulate miR-29a and/or miR-29b in a cell.
A method of improving the appearance of aging skin by stimulating extracellular matrix proteins selected from the group consisting of collagen, elastin, fibrillin, and combinations thereof comprising topically applying to the skin in need of such stimulation a composition containing an effective amount of an active agent that suppresses miR-29a and/or miR-29b, in a topically acceptable vehicle,
- wherein said active agent is a compound having the structure of formula II:
- wherein,
- R5 is selected from hydrogen;
- —R;
- or X1;
- where “m” is an integer from 0 to 5, and, in the case where “m” is 2, 3 or 4, R5 is independently selected at each occurrence;
- and
- R7 and R8 are independently C1-20 hydrocarbon radicals;
- wherein said C1-20 hydrocarbon radicals may optionally be substituted with a group X1 and/or with from one to six heteroatoms selected from oxygen, nitrogen, and sulfur;
- R, R*, and RN are independently hydrogen or a C1-20 hydrocarbon radical;
- wherein said C1-20 hydrocarbon radical may optionally be substituted with a group X1 and/or with from one to twelve heteroatoms selected from oxygen, nitrogen, and sulfur;
- and
- X1 is selected from the group consisting of —F;
- —Cl;
- —Br;
- —I;
- —OH;
- —C≡C—R*;
- —C≡N;
- —C(R)═N—RN;
- —C═N—N(RN)2;
- —C(═NRN)—N(RN)2;
- —CH2OH;
- —CHO;
- —(C═O)—R*;
- —CO2H;
- —CO2−;
- —CO2R*;
- —CS2R*;
- —(C═O)—S—R*;
- —S—(C═O)—R*;
- —(C═O)—NH2;
- —(C═O)—NRNRN;
- —(C═O)—NHNH2;
- —O—(C═O)—NHNH2;
- —(C═S)—NH2;
- —(C═S)—N(RN)2;
- —O—(C═O)—H;
- —O—(C═O)—R*;
- —O—(C═O)—NH2;
- —O—(C═O)—NRNRN;
- —OR*;
- —SR*;
- —NH2;
- —NHRN;
- —NRN2;
- —N(RN)3+;
- N(RN)—OH;
- —N(→O)(R*)2;
- —O—N(RN)2;
- —N(RN)—O—R*;
- —N(RN)—N(RN)2;
- —NRN—(C═O)R*;
- —NRNC(═O)O—R*;
- —NRN—CHO;
- —NRN—(C═O)—R*;
- —NRNC(═O)NRN;
- —N(RN)—C(═O)—N(RN)2;
- —N(RN)—C(═S)—N(RN)2;
- —N═C(R*)2;
- —N═N—RN;
- —SCN;
- —NCS;
- —NSO;
- —SS—R*;
- —SO—R*;
- —SO2—R*;
- —O—S(═O)2—R*;
- —S(═O)2—OR*;
- —N(RN)—SO2—R*;
- —SO2—N(R*)2;
- —O—SO3−;
- —O—S(═O)2—OR*;
- —O—S(═O)—OR*;
- —O—S(═O)—R*;
- —S(═O)—OR*;
- —S(═O)—R*;
- —NO;
- —NO2;
- —NO3;
- —O—NO;
- —O—NO2;
- —N3;
- —N2;
- —N(C2H4);
- —Si(R*)3;
- —CF3;
- —O—CF3;
- —(C═O)—R*;
- —P(R*)2;
- —O—P(═O)(OR*)2;
- and —P(═O)(OR*)2;
- and cosmetically acceptable salts thereof.
Dependencies are inferred from the claim text.